We are live on ! Find out more
Slate Path Capital

Slate Path Capital Portfolio holdings

AUM $6.28B Turnover 28.57%
1-Year Est. Return 54.72%
 

Slate Path Capital runs hedge funds that go long and short on stocks around the world, with sizeable positions in other assets too. The firm was established in 2012 and is owned by David Greenspan and JADES GP, a company in which Greenspan is the principal owner. Its stock picking rests on company research, and it aims for long-term growth adjusted for risk. Its two main funds use significant leverage and concentrated positions, and the firm can also trade digital assets such as Bitcoin and Ethereum. One group of its funds avoids long positions in fossil fuel assets.

This Fund
S&P 500
This Quarter Est. Return
-6.8%
1 Year Est. Return
+54.72%
3 Year Est. Return
+340.87%
5 Year Est. Return
+414.5%
10 Year Est. Return
+4,982.86%
AUM
$2.22B
AUM Growth
-$1.35B
Cap. Flow
+$165M
Cap. Flow %
7.43%
Top 10 Hldgs %
79.23%
Holding
26
New
8
Increased
4
Reduced
2
Closed
6
Avg Time Held Equity + Options
0.5 years
Top 10 Avg Time Held Equity + Options
0.5 years
Top 20 Avg Time Held Equity + Options
0.5 years
Avg Time Held Equity only
0.5 years
Top 10 Avg Time Held Equity only
0.5 years
Top 20 Avg Time Held Equity only
0.5 years

Top Sells

Rank Stock Value
1
TCOM icon
Trip.com Group
TCOM
+$93.8M
2
ALLE icon
Allegion
ALLE
+$93.5M
3
ENDP
Endo International
ENDP
+$77.7M
4
ISRG icon
Intuitive Surgical
ISRG
+$55.4M

Sector Composition

Rank Sector Weight
1 Miscellaneous 43.62%
2 Communication Services 16.75%
3 Healthcare 16.5%
4 Energy 8.35%
5 Materials 5.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
DIA icon
1
PUT
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
$42B
$510M 22.95%
+3,000,000
New +$508M
2014 Q3
0 quarters
SPY icon
2
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$732B
$296M 13.29%
1,500,000
-350,000
-19% -$69.2M
2014 Q2
1 quarter
IWM icon
3
PUT
iShares Russell 2000 ETF
IWM
$70.6B
$164M 7.38%
+1,500,000
New +$172M
2014 Q3
0 quarters
CHTR icon
4
Charter Communications
CHTR
$14.7B
$138M 6.2%
910,000
– –
2013 Q2
5 quarters
WBA icon
5
DELISTED
Walgreens Boots Alliance
WBA
$133M 5.99%
+2,245,000
New +$147M
2014 Q3
0 quarters
P icon
6
DELISTED
Pandora Media
P
$123M 5.55%
5,105,000
+1,280,000
+33% +$34M
2013 Q3
4 quarters
AIG icon
7
AIG
AIG
$41.3B
$106M 4.76%
1,960,000
– –
2013 Q2
5 quarters
B icon
8
Barrick Mining
B
$51.4B
$103M 4.63%
7,027,000
– –
2014 Q1
2 quarters
SIRI icon
9
SiriusXM
SIRI
$10.4B
$101M 4.54%
2,894,000
– –
2013 Q2
5 quarters
ISRG icon
10
Intuitive Surgical
ISRG
$138B
$87.7M 3.95%
1,710,000
-1,116,000
-39% -$55.4M
2014 Q2
1 quarter
MPC icon
11
Marathon Petroleum
MPC
$100B
$87.2M 3.92%
2,060,000
+1,090,000
+112% +$46.3M
2013 Q4
3 quarters
ALNY icon
12
Alnylam Pharmaceuticals
ALNY
$19.3B
$66.8M 3%
855,000
+257,000
+43% +$16.6M
2013 Q2
5 quarters
ANDV
13
DELISTED
Andeavor
ANDV
$64.3M 2.89%
+1,055,000
New +$65M
2014 Q3
0 quarters
ZNGA
14
DELISTED
Zynga
ZNGA
$61.6M 2.77%
+22,800,000
New +$68.3M
2014 Q3
0 quarters
IPXL
15
DELISTED
Impax Laboratories
IPXL
$55.2M 2.48%
+2,330,000
New +$59.7M
2014 Q3
0 quarters
YOKU
16
DELISTED
Youku Tudou
YOKU
$49.4M 2.22%
2,755,000
+550,000
+25% +$11.1M
2014 Q2
1 quarter
PBF icon
17
PBF Energy
PBF
$7.46B
$34.1M 1.53%
1,420,000
– –
2013 Q2
5 quarters
MDCO
18
DELISTED
Medicines Co
MDCO
$24M 1.08%
+1,075,000
New +$27.3M
2014 Q3
0 quarters
TPCO
19
DELISTED
Tribune Publishing
TPCO
$10.2M 0.46%
+506,531
New +$10.2M
2014 Q3
0 quarters
CLF icon
20
Cleveland-Cliffs
CLF
$6.09B
$8.88M 0.4%
855,000
– –
2014 Q2
1 quarter
ALLE icon
21
Allegion
ALLE
$15.5B
– –
-1,650,000
Closed -$93.5M –
QQQ icon
22
PUT
Invesco QQQ Trust
QQQ
$418B
– –
-2,500,000
Closed -$235M –
SPY icon
23
CALL
State Street SPDR S&P 500 ETF Trust
SPY
$732B
– –
-9,100,000
Closed -$1.78B –
TCOM icon
24
Trip.com Group
TCOM
$25.5B
– –
-2,930,000
Closed -$93.8M –
ENDP
25
DELISTED
Endo International
ENDP
– –
-1,110,000
Closed -$77.7M –

Similar funds

Slate Path Capital's Q3 2014 Portfolio in Review

As of Q3 2014, Slate Path Capital held 26 positions worth $2.22B, down 38% from $3.58B the previous quarter. Its ten largest holdings account for 79% of the portfolio.

Slate Path Capital deployed $165M of net new capital in Q3 2014, opening 8 new positions and adding to 4 existing holdings. Its largest new stake was Walgreens Boots Alliance: 2,245,000 shares worth $133M.

By sector, the portfolio is most concentrated in Miscellaneous at 44% of assets, down from 67% a quarter earlier, followed by Communication Services and Healthcare.

On the sell side, the largest reduction was Intuitive Surgical, an estimated $55.4M trimmed.

  • Slate Path Capital's largest Q3 2014 buy was Walgreens Boots Alliance: 2,245,000 shares worth $133M.
  • Slate Path Capital added most to Marathon Petroleum in Q3 2014, an estimated $46.3M increase.
  • Slate Path Capital's biggest Q3 2014 reduction was Intuitive Surgical, cutting an estimated $55.4M.
  • Slate Path Capital fully exited Trip.com Group in Q3 2014, selling an estimated $93.8M.
  • Slate Path Capital's ten largest holdings make up 79% of its $2.22B portfolio in Q3 2014.
  • Slate Path Capital opened 8 new positions and closed 6 in Q3 2014.
  • Slate Path Capital's portfolio value fell 38% quarter-over-quarter to $2.22B.

Based on Slate Path Capital's 13F filing for Q3 2014, filed 14 Nov 2014.